戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r run-on assay and of chromatin structure by nuclease protection assay.
2 ease in TPO mRNA levels as measured by an S1 nuclease protection assay.
3 s in intestinal lymphocytes were assessed by nuclease protection assays.
4 evels using reverse transcription-PCR and S1 nuclease protection assays.
5 tivities were consistent with the results of nuclease protection assays.
6  length of DNA that is protected by RAD52 in nuclease protection assays.
7 ' rapid amplification of cDNA end-PCR and S1 nuclease protection assays.
8 (NTRs) were assayed for RNA production by S1 nuclease protection assays.
9  mRNA with the use of solution hybridization-nuclease protection assays.
10                                        An S1 nuclease protection assay and a Western blot analysis sh
11 ifically methylated U1939 as determined by a nuclease protection assay and by methylation assays usin
12                                      Both S1 nuclease protection assay and primer extension study sug
13                                              Nuclease protection assay and qRT-PCR analysis demonstra
14                              Quantitative S1 nuclease protection assays and a promoterless catechol d
15                                              Nuclease protection assays and mutational analysis revea
16 CE (rapid amplification of cDNA ends) and S1 nuclease protection assays and was at the site of an act
17 d metabolism of btuB RNA were analyzed by S1 nuclease protection assays, and mutations that alter the
18 ption/polymerase chain reaction analysis and nuclease protection assay, BAT was demonstrated to expre
19                                           In nuclease protection assays both proteins protected an in
20                                           S1 nuclease protection assays corroborated these findings,
21 n start site was identified in rat kidney by nuclease protection assay defining a 5' untranslated reg
22 d amplification of cDNA ends coupled with S1 nuclease protection assays demonstrate that the M3 prote
23                                        An S1 nuclease protection assay demonstrated that AlgR repress
24                                              Nuclease protection assays demonstrated highest expressi
25 nscripts by primer extension and modified S1 nuclease protection assays demonstrated that transcripti
26 A expression studies, based on a multiplexed-nuclease protection assay, demonstrated that cell cycle-
27 them to high-throughput genomic quantitative nuclease protection assay for quantifying simultaneously
28                                           S1 nuclease protection assays indicated that this 34-bp cis
29 osing the basic mechanistic principle of the nuclease protection assay into this biosensor framework,
30 g-1 cDNA, and it was further demonstrated by nuclease protection assay, Northern blotting, and immuno
31 amined by a variety of methods, including S1 nuclease protection assays, Northern blotting, Western b
32                                           S1 nuclease protection assays of rpoH P1- and P2-specific e
33  transcription-PCR analyses, coupled with S1 nuclease protection assays, provided evidence that gene
34           Here we show that the quantitative nuclease protection assay (qNPA) enables transcriptional
35                       We used a quantitative nuclease protection assay (qNPA) to analyze formalin-fix
36                                           S1 nuclease protection assays revealed that four ftsZ trans
37                                              Nuclease protection assays revealed that the hippocampus
38                              Furthermore, S1 nuclease protection assays show that Cibacron blue cause
39                                        An S1 nuclease protection assay showed that the start of the d
40                                              Nuclease protection assays showed maximal levels of TrkB
41 ession studies, again based on a multiplexed-nuclease protection assay, showed that TGF-beta-related
42 ormed using a novel multiplexed quantitative nuclease protection assay that involves customized DNA m
43 apid amplification of cDNA ends as well as a nuclease protection assay to map the transcriptional sta
44        Here, we use single-molecule FRET and nuclease protection assays to monitor telomere DNA struc
45                                           S1 nuclease protection assays using a probe which hybridize
46                            A quantitative S1 nuclease protection assay was developed to allow compari
47                                      Using a nuclease protection assay, we demonstrated induction of
48 y 5'-rapid amplification of cDNA ends and S1 nuclease protection assay, we determined that the transc
49 of cDNA ends, primer extension analysis, and nuclease protection assay, we identified transcription s
50  polymerase chain reaction, and quantitative nuclease protection assays, we assessed the ability of s
51              Using both in vitro pairing and nuclease protection assays, we demonstrate that the tran
52                                           S1 nuclease protection assays were used to determine transc
53                                              Nuclease protection assays were used to determine whethe
54                      Primer extension and S1 nuclease protection assays were used to identify two tra
55                       Solution hybridization-nuclease protection assays were used to quantify NK-1 re
56                              RNA binding and nuclease protection assays with a variety of pre-tRNA su

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。